Acquisition Pivots this Firm to Psychedelic Drug Development
21 January 2022 - 6:18AM
AllPennyStocks.com
The exploration of psychedelics for mental health treatment is a
growing opportunity and this firm is ceasing its current operations
to focus on drug development with its new acquisition.
...
To read the full story on AllPennyStocks.com, click
here.
Blue Water Ventures (PK) (USOTC:BWVI)
Historical Stock Chart
From Apr 2024 to May 2024
Blue Water Ventures (PK) (USOTC:BWVI)
Historical Stock Chart
From May 2023 to May 2024